FDA Inspection
The Compounding PHY of Beverly HillsThe Compounding PHY of Beverly Hills – FDA Inspection, Aug 16, 2019
Record Details
This FDA Inspection record concerns The Compounding PHY of Beverly Hills, with an inspection on August 16, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 688f8cc2-878e-49db-9ca5-7011a205bef9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1099856
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.